- Home
- ALDX vs ACTG Comparison
ALDX vs ACTG Comparison
Compare ALDX & ACTG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ALDX
- ACTG
- Stock Information
- Founded
- ALDX 2004
- ACTG 1993
- Country
- ALDX United States
- ACTG United States
- Employees
- ALDX N/A
- ACTG N/A
- Industry
- ALDX Biotechnology: Pharmaceutical Preparations
- ACTG Multi-Sector Companies
- Sector
- ALDX Health Care
- ACTG Miscellaneous
- Exchange
- ALDX Nasdaq
- ACTG Nasdaq
- Market Cap
- ALDX 296.0M
- ACTG 314.4M
- IPO Year
- ALDX 2014
- ACTG 1996
- Fundamental
- Price
- ALDX $4.72
- ACTG $3.55
- Analyst Decision
- ALDX Strong Buy
- ACTG
- Analyst Count
- ALDX 2
- ACTG 0
- Target Price
- ALDX $9.50
- ACTG N/A
- AVG Volume (30 Days)
- ALDX 625.1K
- ACTG 201.8K
- Earning Date
- ALDX 11-05-2025
- ACTG 11-05-2025
- Dividend Yield
- ALDX N/A
- ACTG N/A
- EPS Growth
- ALDX N/A
- ACTG N/A
- EPS
- ALDX N/A
- ACTG 0.05
- Revenue
- ALDX N/A
- ACTG $283,949,000.00
- Revenue This Year
- ALDX N/A
- ACTG $109.86
- Revenue Next Year
- ALDX $63.48
- ACTG N/A
- P/E Ratio
- ALDX N/A
- ACTG $71.03
- Revenue Growth
- ALDX N/A
- ACTG 71.28
- 52 Week Low
- ALDX $1.14
- ACTG $2.70
- 52 Week High
- ALDX $7.20
- ACTG $4.78
- Technical
- Relative Strength Index (RSI)
- ALDX 34.90
- ACTG 54.32
- Support Level
- ALDX $4.85
- ACTG $3.24
- Resistance Level
- ALDX $5.27
- ACTG $3.72
- Average True Range (ATR)
- ALDX 0.27
- ACTG 0.15
- MACD
- ALDX -0.05
- ACTG 0.01
- Stochastic Oscillator
- ALDX 14.15
- ACTG 61.46
About ALDX Aldeyra Therapeutics Inc.
Aldeyra Therapeutics Inc is a biotechnology company engaged in developing and commercializing next-generation medicines to improve the lives of patients with immune-mediated and metabolic diseases. The company's product candidate, Reproxalap, is a treatment in late-stage development for dry eye disease and allergic conjunctivitis. In addition, it also has additional product candidates in development for proliferative vitreoretinopathy, primary vitreoretinal lymphoma and other retinal diseases, autoimmune disease, and cancer. Company products includes ADX248, ADX743, ADX631, ADX246, ADX629, ADX2191.
About ACTG Acacia Research Corporation (Acacia Tech)
Acacia Research Corp is focused on acquiring and operating businesses across the industrial, energy, and technology sectors where it believes it can leverage its expertise, capital base, and deep industry relationships to drive value. The company has four reportable business segments: Intellectual Property Operations, Industrial Operations, Energy Operations and Manufacturing Operations. It derives revenue from Intellectual Property Operations segment. Geographically, it operates in Americas, Europe, Middle East and Africa, China, India, and Asia-Pacific, excluding China and India.